+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Antibe Therapeutics Inc (ATE) - Financial and Strategic SWOT Analysis Review

  • ID: 4285007
  • SWOT Analysis
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Antibe Therapeutics Inc (Antibe) is a biotechnology company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen derivative for osteoarthritis, rheumatoid arthritis and ankylosing spondylitis; ATB-352 for gout, dysmenorrhea, dental pain, post-surgical pain, and ATB-340 for chronic prevention of cardiovascular disease and cancer chemoprevention. Antibe also offers regenerative medical devices, which include CGX-227, CGX-443 and CGX-276 which are indicated for oral and maxillofacial surgery. The company distributes its products across Europe, the Americas, the Middle East and Asia.Antibe is headquartered in Toronto, Ontario, Canada.

Antibe Therapeutics Inc Key Recent Developments

Nov 28, 2017: Antibe Therapeutics Reports Q2 2018 Interim Financial and Operating Results and Provides Corporate Update
Oct 26, 2017: Antibe Therapeutics Announces Key US Distribution Partnership for Its Subsidiary, Citagenix
Aug 29, 2017: Antibe Therapeutics Reports Q1 2018 Interim Financial and Operating Results
Mar 01, 2017: Antibe Therapeutics Reports Q3 2017 Interim Financial and Operating Results

This comprehensive SWOT profile of Antibe Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Antibe Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Antibe Therapeutics Inc - Key Information
  • Antibe Therapeutics Inc - Overview
  • Antibe Therapeutics Inc - Key Employees
  • Antibe Therapeutics Inc - Key Employee Biographies
  • Antibe Therapeutics Inc - Key Operational Heads
  • Antibe Therapeutics Inc - Major Products and Services
  • Antibe Therapeutics Inc - History
  • Antibe Therapeutics Inc - Company Statement
  • Antibe Therapeutics Inc - Locations And Subsidiaries
  • Antibe Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Antibe Therapeutics Inc - Business Description
  • Antibe Therapeutics Inc - Corporate Strategy
  • Antibe Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Antibe Therapeutics Inc - Strengths
  • Antibe Therapeutics Inc - Weaknesses
  • Antibe Therapeutics Inc - Opportunities
  • Antibe Therapeutics Inc - Threats
  • Antibe Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Antibe Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Antibe Therapeutics Inc, Key Information
  • Antibe Therapeutics Inc, Key Ratios
  • Antibe Therapeutics Inc, Share Data
  • Antibe Therapeutics Inc, Major Products and Services
  • Antibe Therapeutics Inc, History
  • Antibe Therapeutics Inc, Key Employees
  • Antibe Therapeutics Inc, Key Employee Biographies
  • Antibe Therapeutics Inc, Key Operational Heads
  • Antibe Therapeutics Inc, Other Locations
  • Antibe Therapeutics Inc, Subsidiaries
  • Antibe Therapeutics Inc, Key Manufacturing facilities
  • Antibe Therapeutics Inc, Key Competitors
  • Antibe Therapeutics Inc, SWOT Analysis
  • Antibe Therapeutics Inc, Ratios based on current share price
  • Antibe Therapeutics Inc, Annual Ratios
  • Antibe Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Antibe Therapeutics Inc, Performance Chart
  • Antibe Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3